ARGO Reality

ARGO Reality

ICO Ended
14,147 Views
For the generation Z online has become a customary habitat. Those businesses who can endow the physical world around with all the properties of the digital one will strategically win.

In July 2017 within the framework of this logic we launched to the market our minimum viable product Go2me.

It was a series of mobile quests using augmented reality. Players enjoyed a variety of tangible prizes - goods and coupons for popular brands. The MVP was done in partnership with one of the largest shopping centers in Minsk.
7.6
TOTAL SCORE
6.9
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
ICO Time: 15 Mar 2018 - 01 Apr 2018
Country: Belarus
Token info
Ticker: ARGO
Platform: Ethereum
Token Type: ERC20
Available for sale: 586,200,000 ARGO
Financial
ICO Price: 1 ARGO = 0.000023 ETH
Accepting: ETH
02.2017
Concept development.
05.2017
Prototype development.
08.2017
MVP test run.
03.2018
Pre-ICO.
06.2018
Soft launch in Minsk/Belarus.
12.2018
Soft Launch in London/UK.
06.2019
Full scale launch in London/UK.
06.2019
Project scaling in major cities.
Alexey Pushkarev
Participates in a number of projects
Crichton Brauer
Participates in a number of projects
Dmitry Ezersky
Participates in a number of projects
Vasily Veko
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
Burency
Burency is an advocate for crypto and Blockchain adoption, particularly in the MIDDLE EAST. The platform is designed to address key challenges that prevent widespread adoption within the cryptocurrency and Blockchain ecosystem such as exchange’s lack of liquidity and security, unsustainable mining, unawareness of Blockchain applications to businesses. The Burency Exchange is a regulated exchange platform that addresses key challenges including security, liquidity, fiat to crypto transactions and vise versa, and more. The exchange is one of the world’s fully insured platforms, with coverage provided from LIoyd’s of London through the Nebbex Protocol. The Burency Mining facility answers some of the challenges associated with crypto mining such as mining destruction to environment and excessive mining power expenses by creating a sustainable facility powered by renewable hydropower. Burency provides a streamlined platform for the generation of cryptocurrency via purchased timeshare slots within the mining facilities using the BUY token. Additionally, computational power can also be purchased via the BUY token which governs purchases across the Burency ecosystem. The Burency Blockchain Development Center is dedicated mainly for advising enterprises on Blockchain applications and helping them operate on the blockchain for more efficient operation and business transactions execution. In particular, the center focuses on the creation of smart contracts that enable businesses to trade with entities across geographical and jurisdiction boundaries.
Upcoming
TillBilly
TillBilly aims to bring blockchain to the mainstream retail. TillBilly is a Stellar based digital payments network with a unique point of sale hardware terminal that empowers everyday shoppers to make contactless payments, automatically get digital receipts (tax invoices) and collect loyalty reward points, without the complexity or price volatility associated with cryptocurrencies TillBilly bypasses the middlemen Merchant Services providers (card processing companies, payment gateways) who charge high processing fees per transaction (1.5% - 3.5%) and provides an ultra low fee payments network, so the shopper pays less, and the merchant gets more Protects both shoppers and merchants against any cryptocurrency price volatility. Provides a seamless way of funding wallets within app, and making payments through our proprietary tap-and-go (NFC) payment terminals. Complexities of blockchain and cryptocurrencies are hidden from shoppers and merchants.
Upcoming
Candao
"People can, DAO's do. Candao mission is to create a platform where individuals with the same business and social goals can come together to inspire, engage and build values together. Candao unlock people’s superpowers and let them tokenize the value they create, liquefy assets, connect existing ones, bring people together in order to build joint ventures, distribute profits between all involved people and unlock the value of everyone who plays different roles in everyday life."
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.